NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE SINUS AND HEADACHE - naproxen sodium and pseudoephedrine hydrochloride tablet, extended release 
Aurohealth LLC

----------

Naproxen Sodium and Pseudoephedrine Hydrochloride Extended-Release Tablets, USP 220 mg/120 mg Sinus and Headache

Drug Facts

Active ingredients (in each caplet)

Naproxen sodium USP 220 mg (naproxen 200 mg) (NSAID)*
Pseudoephedrine Hydrochloride USP 120 mg, extended-release

*nonsteroidal anti-inflammatory drug

Purposes

Pain reliever/fever reducer

Nasal decongestant

Uses

temporarily relieves these cold, sinus, and flu symptoms:
 

Warnings

Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:

If an allergic reaction occurs, stop use and seek medical help right away.

Stomach bleeding warning:
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:


Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.

Do not use

Ask a doctor before use if

Ask a doctor or pharmacist before use if you are

When using this product

Stop use and ask a doctor if

If pregnant or breast-feeding,

ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

Other information

Inactive ingredients

Colloidal silicon dioxide, croscarmellose sodium, ferric oxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc and titanium dioxide.

Questions or comments?

call 1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)

Distributed by:
AUROHEALTH LLC
279 Princeton-Hightstown Road
East Windsor, NJ 08520

Made in India

Code: AP/DRUGS/04/2016

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 220 mg / 120 mg 10 Caplets (Capsule-Shaped Tablets) Blister Carton Label

NDC 58602-832-83
*Compare to active
ingredients in
Aleve-D® Sinus & Headache
Non-Drowsy
THIS CARTON IS NOT CHILD RESISTANT

Naproxen Sodium and 
Pseudoephedrine Hydrochloride
Extended-Release Tablets, USP 
220 mg/120 mg
Pain Reliever/Fever Reducer (NSAID)
Nasal Decongestant
SINUS & HEADACHE
12 Hour Multi-Symptom Relief of

10 Caplets
(1 x 10's blister)
1 Caplet - 12 Hours
AUROHEALTH



Naproxen Figure
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE SINUS AND HEADACHE 
naproxen sodium and pseudoephedrine hydrochloride tablet, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58602-832
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NAPROXEN SODIUM (UNII: 9TN87S3A3C) (NAPROXEN - UNII:57Y76R9ATQ) NAPROXEN SODIUM220 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE120 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
HYPROMELLOSE 2208 (15000 MPA.S) (UNII: Z78RG6M2N2)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE 101 (UNII: 7T9FYH5QMK)  
MICROCRYSTALLINE CELLULOSE 102 (UNII: PNR0YF693Y)  
POLYETHYLENE GLYCOL 4000 (UNII: 4R4HFI6D95)  
POVIDONE K30 (UNII: U725QWY32X)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorWHITE (White to off-white) Scoreno score
ShapeCAPSULE (Modified Capsule Shaped) Size17mm
FlavorImprint Code L95
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58602-832-831 in 1 CARTON06/01/2022
110 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:58602-832-672 in 1 CARTON06/01/2022
210 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA21136006/01/2022
Labeler - Aurohealth LLC (078728447)
Establishment
NameAddressID/FEIBusiness Operations
APL HEALTHCARE LIMITED650918514ANALYSIS(58602-832) , MANUFACTURE(58602-832)

Revised: 6/2022
Document Id: 10a8a74b-11d1-490e-87e7-d705fe0e7602
Set id: 10a8a74b-11d1-490e-87e7-d705fe0e7602
Version: 1
Effective Time: 20220603
 
Aurohealth LLC